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Abstract Labeling of human colon carcinoma cells with 
[3Hjdol, followed by extensive delipidation and removal of dol-
P oligosaccharides, showed that dol are bound to cellular 
proteins with sizes of 5, 10, 27, 75 and > 140 kDa. HPLC 
purification of proteolytic products of [3H]dol- and [35S]cys-
labeled proteins revealed a hydrophobic peak containing both dol 
and cysteine. The dol/cys-labeled products were clearly separated 
from GG-cys, and exhibited a hydrophobicity between that of 
dol-P and dol. In another set of experiments delipidated proteins 
were treated with methyl iodide, which cleaves thioether bonds. 
After HPLC purification of released dol-like lipids, these were 
subjected to mass spectrometry. This demonstrated molecular 
ions with the same mass as that of dol. Taken together our data 
provide evidence for the existence of proteins covalently modified 
with dol. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Thirteen years ago Glomset and coworkers reported that 
compounds derived from MVA are covalently linked to pro-
teins in mouse 3T3 cells [1]. It was later shown that farnesyl 
(C15; three isoprene units) or G G (C20; four isoprene units) 
groups were coupled to the carboxy terminal of certain pro-
teins through a thioether bond [2-4]. 
Theoretically, protein prenylation might include modifica-
tions with isoprene moieties other than farnesyl or G G 
groups, e.g. long-chain compounds such as polyprenols or 
dol (C85-110; 16-22 isoprene units). Although some studies 
have indicated that dol may be bound to proteins [5-7], the 
existence of protein dolichylation still remains to be estab-
lished. The present paper provides evidence that dol is cova-
lently bound to human cell proteins. 
2. Materials and methods 
2.1. Chemicals 
GG-cys and [l-3H]dol were from American Radiolabeled Chemicals 
Inc. Ä,5'-[5-3H]MVA was purchased from DuPont New England Nu-
clear and L-[35S]cys from Amersham. All other chemicals, if not oth-
erwise specified, were from Sigma. 
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2.2. Cell culture 
The human colon carcinoma cell line WiDr, the human melanoma 
cell line SK-MEL-2 and the human hepatoblastoma cell line HepG2 
were purchased from American Type Cell Collection, Rockville, MD, 
USA. All cell lines were grown in monolayers in tissue culture flasks 
maintained in a 95% air/5% CO2 atmosphere at 37°C in a humidified 
incubator. The cells were cultured in minimum essential medium sup-
plemented with 10% fetal calf serum. 
2.3. Isolation of prenylated proteins 
Cells cultured in 15-cm dishes were shifted to fresh serum-free me-
dium containing 50 μ θ [3H]MVA/ml (50.1 Ci/mmol) or 6.0 \iCi 
[3H]dol (dol-16-dol-22)/ml (1-2 Ci/mmol) or 5.0 μ θ [35S]cys/ml 
(1297 Ci/mmol). Proteins were isolated in the presence of protease 
inhibitors (1.0 μg/ml leupeptin, 1.0 μg/ml aprotinin, 0.7 μg/ml pepsta-
tin and 2 mM phenylmethylsulfonyl fluoride). Delipidation was per-
formed by washing the protein precipitate three times with acetone, 
CM (2:1) and absolute ethanol, as described elsewhere [1,8,9]. In 
order to remove any residual dol-P oligosaccharides the precipitate 
was also washed five times with CMW (10:10:3) [10,11]. 
2.4. Sulfonium salt cleavage with methyl iodide 
The procedure described by Maltese and Erdman [9] was followed. 
2.5. Proteolytic cleavage of radiolabeled proteins 
Proteolytic digestion was performed using protease type XIV from 
Streptomyces griseus (Pronase E) [12]. It was confirmed by SDS-
PAGE that this treatment resulted in total degradation of the cellular 
proteins. The hydrophobic products were extracted by butanol for 
HPLC analysis. 
2.6. HPLC 
Methyl iodide-released dol-like lipids were purified by reversed-
phase and normal-phase HPLC for mass spectrometry as described 
elsewhere [13]. The flow rate in both systems was 1 ml/min and 2-ml 
fractions were collected. Labeled proteolytic butanol-extractable prod-
ucts were purified on a reversed-phase HPLC system consisting of a 
Hypersil WP butyl (C4) column (150X4.6 mm) (Waters). Solvent A 
was methanol/water (1/1) containing 10 mM ammonium acetate, and 
solvent В was 100% isopropanol containing 10 mM ammonium ace-
tate. A linear gradient starting with 95% solvent A and 5% solvent В 
reaching 50% solvent В after 60 min was used. The flow rate was 0.8 
ml/min. In one experiment rechromatography was done on a reversed-
phase HPLC system consisting of a Radial Рак Resolve (5 μpiι) Cig 
cartridge (Waters). Solvent A was methanol/water (95/5) containing 
10 mM ammonium acetate, and solvent В was 100% isopropanol 
containing 10 mM ammonium acetate. After a 5-min isocratic period 
in 95% solvent A and 5% solvent B, a linear gradient was started. 
After 45 min a solvent В concentration of 95% was reached. The flow 
rate was 1.0 ml/min and 2-ml fractions were collected for radioactive 
assay. 
2.7. Gel electrophoresis 
Labeled proteins were fractionated by SDS-PAGE [14] using 10% 
or 15% polyacrylamide gels. The lanes were excised and sliced into 2-
mm segments which were solubilised in 0.5 ml Soluene-350 (Packard). 
8 ml Hionic-Fluor (Packard) was added and the radioactivity deter-
mined by scintillation counting. 
2.8. Mass spectrometry 
Mass spectra were recorded on a VG AutoSpec (VG Analytical, 
Manchester, UK) mass spectrometer. Standard dol (dol-17 and dol-
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19) and biological samples at different sample levels (1 ng-10 μg) were 
introduced individually into the spectrometer electron impact (El) 
source via the direct inlet probe which was heated stepwise from 
200°C to 300°C in 10°C intervals at a rate of 10°C/10 scans as de-
scribed elsewhere [13]. 
3. Results 
[3H]Dol-labeled proteins from WiDr cells were harvested 
for analysis. It has been shown extensively elsewhere that 
dol are taken up by cells when added to the culture medium 
[15]. Approximately 10% of the added [3H]dol was found in 
the cell extract. The [3H]dol-labeled proteins were delipidated 
extensively, including extraction of dol-P oligosaccharides us-
ing CMW. Delipidated proteins from control cells demon-
strated a substantial incorporation of [3H]dol (173000 
DPM/mg protein). The same level of [3H]dol incorporation 
was seen in cells treated with tunicamycin (TM) during the 
labeling period. Since TM is a specific inhibitor of TV-linked 
glycosylation through blocking of the production of N-acetyl-
glucosamine-dol-P [16], this result confirms that the delipida-
tion procedures used efficiently removed dol-P oligosacchar-
ides from the proteins. It was also found that treatment with 
cycloheximide, an inhibitor of de novo protein synthesis, did 
not decrease the [3H]dol labeling of the proteins. This result 
suggests that the binding of dol to the proteins comprises a 
post-translational event. The delipidated [3H]dol-labeled pro-
teins were fractionated by SDS-PAGE (15% or 10% poly-
acrylamide). This gave rise to four peaks with regard to the 
molecular size: 75 kDa, 27 kDa, 10 kDa and 5 kDa, and also 
an uncharacterised peak above 140 kDa (Fig. 1). 
WiDr cells were next labeled with either [3H]MVA, [3H]dol 
or [35S]cys. After delipidation and removal of dol-P oligosac-
charides the labeled proteins were subjected to extensive pro-
teolysis. Fifty to 85% of the [3H]dol labeling of the protein 
digest was extractable with butanol. The corresponding value 
for [35S]cys was only 2%. It was confirmed by SDS-PAGE 
that the aforementioned [3H]dol-labeled peaks (5, 10, 27 and 
75 kDa) were deleted by the proteolytic treatment (data not 
shown). 
The butanol-extractable [35S]cys-, [3H]MVA- and [3H]dol-
labeled proteolytic products were each subjected to reversed-
phase HPLC using a C4 column. The [
3H]MVA-labeled ma-
terial separated into three radioactive peaks (Fig. 2A). The 
most hydrophobic of these (appearing after 45-60 min) co-
eluted with the most hydrophobic [35S]cys-labeled peak (Fig. 
2B). These compounds required 47% isopropanol to be eluted. 
The two less hydrophobic [3H]MVA-labeled peaks (the first 
and second peaks) coeluted with a broad [35S]cys-labeled 
peak. A GG-cys standard coeluted (at 29% isopropanol) 
with the second [3H]MVA-labeled peak and the late aspect 
of the first [35S]cys-labeled peak. It seems likely that the sec-
ond [3H]MVA-labeled peak represented GG-cys, and presum-
ably also farnesyl-cysteine, which would behave similarly to 
GG-cys on this HPLC system. The Chromatographie behav-
iour of the [3H]dol-labeled butanol-soluble protein digest is 
shown in Fig. 2C. As demonstrated, a hydrophobic peak co-
eluting with the late [3H]MVA- and [35S]cys-labeled peaks (cf. 
Fig. 2A,B) appeared. The shapes of the [3H]dol-labeled and 
the [35S]cys-labeled peaks differed somewhat (Fig. 2C). The 
explanation for this might be differences between the distribu-
tion of dol homologues bound to cysteine residues and the 
distribution of [3H]-labeled dol homologues. A dol-P standard 
was found to elute somewhat earlier (at 36% isopropanol) 
than the [3H]dol/[35S]cys-labeled peak, whereas the dol stand-
ard eluted later (at 65% isopropanol) (Fig. 2C). An aliquot 
from fractions corresponding to the hydrophobic peak of 
[3H]MVA-labeled and [35S]cys-labeled proteolytic products 
(see Fig. 2A,B) was rechromatographed on a reversed-phase 
Ci8 column. As shown in Fig. 3, the [3H]MVA- and [35S]cys-
labeled compounds behaved similarly, and eluted later (at 
approximately 40% isopropanol) than dol-P (at 5% isopropa-
nol) but earlier than the neutral dol (at 95% isopropanol) on 
this HPLC system. 
In another set of experiments large amounts of [3H]MVA-
labeled proteins isolated from WiDr, SK-MEL-2 and HepG2 
were, after delipidation and removal of dol-P oligosacchar-
ides, treated with methyl iodide. The released [3H]MVA-la-
beled material was first purified by reversed-phase HPLC. 
Labeled material coeluting with dol standards were rechroma-
tographed on a normal-phase HPLC system, as described else-
where [13]. Fractions corresponding to dol were taken for 
mass spectrometry. Control material was obtained from pro-
teins that had undergone the same hydrolytic treatment but 
with the omission of methyl iodide. 
The molecular ion regions of the El mass spectra of refer-
ence dol-19 and dol-17 were first analysed. Dol-19 vapourises 
at approximately 240°C and has a monoisotopic mass [M]+ of 
1313.2 Da (data not shown). Dol-17 vapourises from the 
probe at around 230°C and has a monoisotopic mass [M]+ 
Mr (kDa) Mr (kDa) 
Fig. 1. Electrophoretic pattern of [3H]dol-labeled proteins. WiDr cells were incubated in medium containing [3H]dol (6 μα/ml) for 48 h. After 
delipidation procedures two parallel protein samples (200 μg each) were fractionated by SDS-PAGE (10% or 15% polyacrylamide). The pro-
tein-containing lanes were sliced and assayed for radioactivity. The molecular weights are based on standard proteins. The experiment was re-
peated with similar results. 
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Fig. 2. C4 reversed-phase HPLC of [
3H]dol-, [3H]MVA- and 
[35S]cys-labeled protein digest. WiDr cells were incubated in medium 
containing [3H]MVA (50 μΟΛηΙ) (A), [35S]cys (5 μα/ml) (В) or 
[3H]dol (6 μα/ml) (C) for 48 h. After delipidation, removal of dol-
P oligosaccharides and extensive proteolysis, the butanol-extractable 
labeled compounds were run on a C4 reversed-phase HPLC system. 
In С the appearance of rechromatographed [35S]cys-labeled products 
is compared with [3H]dol-labeled proteolytic products. The elution 
of external standards for GG-cys, dol-P and dol is indicated. The 
experiment was repeated several times with similar results. 
of 1177.1 Da (data not shown). The isotope patterns were 
almost identical to those calculated from known isotope abun-
dances for C95H1560 (dol-19) and C85H140O (dol-17). Fig. 
4A,B shows the molecular ion regions of the dol-like lipids 
removed by methyl iodide of delipidated proteins from WiDr 
and SK-MEL-2, respectively (see above). The material from 
WiDr (Fig. 4A), which vapourised in the range 200-240°C, 
gave a peak at mlz 1177. Closer inspection of these mass 
regions showed a molecular mass and an isotope pattern sim-
ilar to that calculated for dol-17 (Cg5Hi4oO). The dol-like 
material from SK-MEL-2 vapourised in the range 230-
270°C and gave a molecular ion envelope corresponding to 
СвбНшО with a monoisotopic mass peak at mlz 1191 (Fig. 
4B). It is possible that this is a methylation product of doli-
chol-17, resulting from the methyl iodide treatment of the 
400 
O- 300-
Q 
^ 200 
CO 100-
Dol-P 
Ϊ 
0 1 0 
° — [3H]MVA(DPM) 
γ ·■-■■ [ 3 5 S ] C Y S (СРМ) 
^ | Dol 
ί 
20 30 40 
Retention time 
I 
-120 
■too E 
Q. 
■80 У -
60 £ 
-40 С/Г 
irt 
CO 
-20 '—' 
50 60 
(min.) 
Fig. 3. Cis reversed-phase HPLC of [3H]MVA/[35S]cys-labeled pro-
teolytic products. Fractions corresponding to the late [3H]MVA and 
[35S]cys peaks shown in Fig. 4A,B were rechromatographed on a 
HPLC system with a Ci8 reversed-phase column. The elution of ex-
ternal dol-P and dol standards is indicated. The experiment was re-
peated with similar results. 
original sample. A smaller dol-17 envelope was also present 
(Fig. 4B). In the HepG2 cell material, which vapourised in the 
range 200-240°C, there was also a peak at mlz 1177 (data not 
shown). In all three cases fractions adjacent to those contain-
ing the dol-like lipids did not give rise to any peaks in the 
investigated mass ranges. Furthermore, analysis of a sample 
treated by alkaline hydrolysis without methyl iodide did not 
give rise to any peaks (data not shown). 
4. Discussion 
An intriguing question is whether protein prenylation also 
includes modification with isoprenes other than farnesyl or 
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Fig. 4. Mass spectrometry. [3H]MVA-labeled lipids removed from 
WiDr proteins by methyl iodide were purified by HPLC. Fractions 
corresponding to dol were subjected to El mass spectrometry. A: 
Material from WiDr. B: Material from SK-MEL-2. 
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GG groups. Evidence for protein modification of a cysteine 
residue in Halobacteria halobium with a diphytanylglyceryl 
group through a thioether linkage has recently been demon-
strated by Sagami et al. [9]. Furthermore, Shipton et al. [17] 
showed that methyl iodide hydrolysis of [3H]MVA-labeled 
proteins in spinach releases phytol and some other unidenti-
fied isoprenoid compounds. 
In this study we provide evidence for thioether linkage of 
dol groups to cysteine residues in human cell proteins. Our 
evidence is based on the following three main findings. Firstly, 
[3H]dol was incorporated into cellular proteins, and was not 
released by procedures for extensive delipidation and removal 
of dol-P oligosaccharides. Secondly, extensive proteolysis of 
proteins labeled with [3H]dol, [3H]MVA and [35S]cys resulted 
in hydrophobic products containing both [3H]dolichol/ 
[3H]MVA and [35S]cysteine. The hydrophobicity of these 
products was between that of dol-P and dol. Thirdly, mass 
spectrometry of lipids released by methyl iodide disclosed a 
compound corresponding to dol. 
In the mass spectrometry of the dol-like lipids released by 
methyl iodide, only one homologue (dol-17) could be de-
tected. This does not, however, exclude the possibility that 
other dol homologues are linked to proteins. The reason 
why only dol-17 was detected could be that this homologue 
may constitute the predominant substrate in the dolichylation 
reaction, and therefore be the only homologue exceeding the 
mass spectrometric detection limit. Support for this idea is 
provided by our finding that the peak of [35S]cys-labeled pro-
teolytic products was somewhat skewed towards more polar 
compounds indicating that shorter dol homologues are pref-
erentially linked to cysteine residues. Another possibility is 
that dol-17 may be more stable than the longer homologues 
upon treatment with methyl iodide. It has been reported that 
sulfonium salt cleavage gives rise to hydrophobic rearrange-
ment products derived from farnesol or GG [8]. Similar rear-
rangements most likely also occur in dol, and perhaps longer 
homologues are more sensitive to such reactions. 
An important question which can be raised is whether dol, 
dol-P, or dol-PP constitutes the lipid substrate in this reaction. 
Generally, establishment of a thioether linkage necessitates 
the presence of a pyrophosphate group, because of the re-
quirement for energy in this type of reaction. It therefore 
seems probable that phosphorylated derivatives, rather than 
dol in itself, comprise the substrates in the dolichylation re-
action. Because we labeled the cells with [3H]dol, it is likely 
that phosphorylation takes place before linkage to the pro-
teins. That exogenous dol can undergo phosphorylation has 
been reported in other studies [15,18]. 
Similarly to the covalent linkages of GG and farnesyl 
groups to proteins, the dolichylation reaction seems to occur 
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post-translationally because the reaction was not blocked by 
inhibition of de novo protein synthesis. 
In this study evidence for protein dolichylation is demon-
strated in three human tumour cell lines. Unpublished results 
in our laboratory have, however, shown no evidence for pro-
tein dolichylation in normal fibroblasts. This preliminary re-
sult, taken together with our present data, is interesting since 
it raises the question of whether protein dolichylation is a 
reaction involved in tumour transformation or progression. 
Studies to disclose the nature and intracellular distribution 
of dol-modified proteins and the chemical properties of the 
dolichylation reaction are in progress in our laboratory. 
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